Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Bioverativ Appoints Executive Vice President, Research And Development April 9, 2017 Creative BioMart Launched A Series Of Activities And Promotions Recently March 19, 2017 Adapt Pharma Names President Of U.S. Operations April 11, 2016
